Connect Biopharm Llc
Clinical trials sponsored by Connect Biopharm Llc, explained in plain language.
-
New drug aims to tame COPD Flare-Ups in inflammatory subtype
Disease control Recruiting nowThis study tests whether adding rademikibart to standard care can reduce treatment failures during acute COPD flare-ups in adults with type 2 inflammation. About 160 participants will receive either the drug or a placebo, and researchers will track hospital visits, symptom worsen…
Phase: PHASE2 • Sponsor: Connect Biopharm LLC • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug aims to cut asthma attack failures in half
Disease control Recruiting nowThis study tests whether adding rademikibart to standard asthma care can reduce treatment failures during acute asthma attacks. About 160 adults and teens with asthma and type 2 inflammation will receive either the drug or a placebo. The main goal is to see if fewer people need h…
Phase: PHASE2 • Sponsor: Connect Biopharm LLC • Aim: Disease control
Last updated May 15, 2026 11:53 UTC